Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-Moderate Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00566397
What this trial is testing

Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 402
Testing effectiveness (Phase 2)Study completedNCT02626572
What this trial is testing

Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms

Who this might be right for
Alzheimer's Disease
Institut de Recherches Internationales Servier 500
Large-scale testing (Phase 3)Temporarily pausedNCT04520412
What this trial is testing

Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 2,046
Early research (Phase 1)Study completedNCT00736775
What this trial is testing

The Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT01009255
What this trial is testing

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 196
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07205601
What this trial is testing

Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Regeneration Biomedical, Inc. 115
Not applicableStudy completedNCT04404153
What this trial is testing

Neurostimulation for Cognitive Enhancement in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
Albert Einstein College of Medicine 100
Early research (Phase 1)Study completedNCT02036645
What this trial is testing

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

Who this might be right for
Mild-Moderate Alzheimer's DiseaseHealthy Elderly
AstraZeneca 77
Not applicableUnknownNCT03352739
What this trial is testing

Fornix and NbM as Targets of Stimulation In Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 30
Early research (Phase 1)Study completedNCT00988598
What this trial is testing

A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 15
Not applicableStudy completedNCT01893398
What this trial is testing

Multistimulation Group Therapy for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Fondazione Don Carlo Gnocchi ETS 60
Not applicableStudy completedNCT00348309
What this trial is testing

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 1,496
Early research (Phase 1)Study completedNCT02754830
What this trial is testing

LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 72
Not applicableUnknownNCT04021888
What this trial is testing

The Effects of Exercise Program in Alzheimer's Patients With Mild to Moderate Stage Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAerobic ExerciseBreathing Exercise+1 more
Dokuz Eylul University 60
Testing effectiveness (Phase 2)Study completedNCT01504854
What this trial is testing

Resveratrol for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Alzheimer's Disease Cooperative Study (ADCS) 119
Testing effectiveness (Phase 2)Study completedNCT03493282
What this trial is testing

Effect of CT1812 Treatment on Brain Synaptic Density

Who this might be right for
Alzheimer Disease
Cognition Therapeutics 43
Testing effectiveness (Phase 2)Study completedNCT06694597
What this trial is testing

Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Fujian Medical University Union Hospital 76
Post-approval studies (Phase 4)UnknownNCT05383183
What this trial is testing

Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Daewoong Bio Inc. 630
Large-scale testing (Phase 3)Study completedNCT01614886
What this trial is testing

Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 216
Large-scale testing (Phase 3)Ended earlyNCT00490568
What this trial is testing

Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 1,461
Next Page